Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Lieke H.J. Simkens"'
Autor:
Mathijs P. Hendriks, J M van Dodewaard-de Jong, J W T Dekker, J.A.G. van der Heijden, Bastiaan R. Klarenbeek, A J G Maaskant-Braat, D J A Sonneveld, T van Voorthuizen, Hein B.A.C. Stockmann, L B J Valkenburg-van Iersel, I.H.J.T. de Hingh, F W H Kloppenberg, G R Vink, Seyed M. Qaderi, F H Beverdam, K Talsma, A H W Schiphorst, J F J Vogelaar, Frans L. G. Erdkamp, H W M U van Grevenstein, W J Vles, Marco B. Polee, Jan B.M.J. Jansen, H H Helgason, P P L O Coene, Geerard L. Beets, E J Th Belt, A U G van Lent, Jan N. M. IJzermans, D D E Zimmerman, M L R Tjin-A-Ton, A J ten Tije, M Berbée, Leonie J. M. Mekenkamp, M P S Sie, Annebeth W. Haringhuizen, Koen C.M.J. Peeters, Maartje Los, A M T van der Velden, N A J B Peters, J W B de Groot, Martijn R. Meijerink, A Schouten van der Velden, A I de Vos, J.H.W. de Wilt, Lieke H.J. Simkens, E G G Verdaasdonk, José A. E. Custers, Peter Nieboer, Rob H.A. Verhoeven, M Vermaas, F Terheggen, P Quarles van Ufford-Mannesse, R Blankenburgh, R Hoekstra, R W M Schrauwen, Dirkje W. Sommeijer, R C Rietbroek, H van Cruijsen, L E A Spierings
Publikováno v:
British journal of surgery, 108(8), 991-997. John Wiley and Sons Ltd
British Journal of Surgery, 108(8), 991-997. Wiley
PLCRC group 2021, ' Transanal total mesorectal excision and low anterior resection syndrome ', British Journal of Surgery, vol. 108, no. 8, pp. 991-997 . https://doi.org/10.1093/bjs/znab056
British Journal of Surgery, 108, 8, pp. 991-997
British Journal of Surgery, 108, 991-997
British Journal of Surgery, 108(8), 991-997. John Wiley and Sons Ltd
British Journal of Surgery, 108(8), 991-997. Wiley
PLCRC group 2021, ' Transanal total mesorectal excision and low anterior resection syndrome ', British Journal of Surgery, vol. 108, no. 8, pp. 991-997 . https://doi.org/10.1093/bjs/znab056
British Journal of Surgery, 108, 8, pp. 991-997
British Journal of Surgery, 108, 991-997
British Journal of Surgery, 108(8), 991-997. John Wiley and Sons Ltd
Background Bowel dysfunction after rectal cancer surgery is common, with some experiencing low anterior resection syndrome (LARS) is common after rectal cancer surgery. This study examined if transanal total mesorectal excision (TaTME) has a similar
Autor:
Judith de Vos-Geelen, Lotte Keikes, Jan Willem de Groot, Miriam Koopman, Lieke H.J. Simkens, A. Vos, Martijn G.H. van Oijen, Marija Trajkovic-Vidakovic, Cornelis J. A. Punt, Johanneke E.A. Portielje, Cornelis B. Hunting, Laurens V. Beerepoot
Publikováno v:
Patient education and counseling, 102(7), 1331-1335. Elsevier Ireland Ltd
Patient Education and Counseling, 102(7), 1331-1335. Elsevier Ireland Ltd
Patient Education and Counseling, 102(7), 1331. Elsevier Ireland Ltd
Patient Education and Counseling, 102(7), 1331-1335. Elsevier Ireland Ltd
Patient Education and Counseling, 102(7), 1331. Elsevier Ireland Ltd
Objective: To examine implementation and patients' and providers' participation and satisfaction of a newly developed decision support tool (DST) for patients with metastatic colorectal cancer (mCRC) in palliative setting.Methods: Our DST consisted o
Autor:
Gerrit Jan Veldhuis, Edith B. van Druten, Cathrien S. Tromp-van Driel, Ronald C. Rietbroek, Gerty J. de Klerk, Annebeth W. Haringhuizen, Theo van Voorthuizen, J. E. Vincent, Manuel L. R. Tjin-A-Ton, Anne M. May, Ankie M.T. van der Velden, Geraldine R. Vink, Brigitte C. M. Haberkorn, J. Cornelis B. Hunting, Joyce M. van Dodewaard-de Jong, R. Hoekstra, Lieke H.J. Simkens, Sandra D. Bakker, Patricia Quarles van Ufford-Mannesse, Jeanine M.L. Roodhart, Geert-Jan Creemers, Marjan A. van Dijk, Marco B. Polee, G. Emerens Wensink, Cornelis J. A. Punt, Daan ten Bokkel Huinink, Marloes A. G. Elferink, Bea Tanis, Franchette W P J van den Berkmortel, Henk M.W. Verheul, Danielle Mathijssen-van Stein, Miriam Koopman, Hanneke J. H. M. J. Vestjens, Sandra A Radema, J.F.M. Pruijt, Monique M. Troost, Onno Kranenburg, Jan Willem B. de Groot, Anke J. M. van der Pas, Agnes J. van de Wouw, Emile D. Kerver, Patricia A. H. Hamers, Linda Mol
Publikováno v:
British Journal of Cancer, 124(2), 399-406. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer, 124, 399-406
British journal of cancer, 124(2), 399-406. Nature Publishing Group
British Journal of Cancer, 124, 2, pp. 399-406
Wensink, G E, Elferink, M A G, May, A M, Mol, L, Hamers, P A H, Bakker, S D, Creemers, G-J, de Groot, J W B, de Klerk, G J, Haberkorn, B C M, Haringhuizen, A W, Hoekstra, R, Hunting, J C B, Kerver, E D, Mathijssen-van Stein, D, Polée, M B, Pruijt, J F M, Quarles van Ufford-Mannesse, P, Radema, S, Rietbroek, R C, Simkens, L H J, Tanis, B C, ten Bokkel Huinink, D, Tjin-A-Ton, M L R, Tromp-van Driel, C S, Troost, M M, van de Wouw, A J, van den Berkmortel, F W P J, van der Pas, A J M, van der Velden, A M T, van Dijk, M A, van Dodewaard-de Jong, J M, van Druten, E B, van Voorthuizen, T, Jan Veldhuis, G, Verheul, H M W, Vestjens, H J H M J, Vincent, J, Kranenburg, O W, Punt, C J A, Vink, G R, Roodhart, J M L & Koopman, M 2021, ' Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era ', British Journal of Cancer, vol. 124, no. 2, pp. 399-406 . https://doi.org/10.1038/s41416-020-01076-0
British Journal of Cancer
British Journal of Cancer, 124, 399-406
British journal of cancer, 124(2), 399-406. Nature Publishing Group
British Journal of Cancer, 124, 2, pp. 399-406
Wensink, G E, Elferink, M A G, May, A M, Mol, L, Hamers, P A H, Bakker, S D, Creemers, G-J, de Groot, J W B, de Klerk, G J, Haberkorn, B C M, Haringhuizen, A W, Hoekstra, R, Hunting, J C B, Kerver, E D, Mathijssen-van Stein, D, Polée, M B, Pruijt, J F M, Quarles van Ufford-Mannesse, P, Radema, S, Rietbroek, R C, Simkens, L H J, Tanis, B C, ten Bokkel Huinink, D, Tjin-A-Ton, M L R, Tromp-van Driel, C S, Troost, M M, van de Wouw, A J, van den Berkmortel, F W P J, van der Pas, A J M, van der Velden, A M T, van Dijk, M A, van Dodewaard-de Jong, J M, van Druten, E B, van Voorthuizen, T, Jan Veldhuis, G, Verheul, H M W, Vestjens, H J H M J, Vincent, J, Kranenburg, O W, Punt, C J A, Vink, G R, Roodhart, J M L & Koopman, M 2021, ' Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era ', British Journal of Cancer, vol. 124, no. 2, pp. 399-406 . https://doi.org/10.1038/s41416-020-01076-0
BackgroundMetastatic colorectal cancer patients with deficient mismatch repair (dMMR mCRC) benefit from immunotherapy. Interpretation of the single-arm immunotherapy trials is complicated by insignificant survival data during systemic non-immunothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0117d001dca85f91775734a7c4208f2d
https://research.vumc.nl/en/publications/4d0a604d-b0c0-44c7-b106-5b8d5ff6f3c4
https://research.vumc.nl/en/publications/4d0a604d-b0c0-44c7-b106-5b8d5ff6f3c4
Autor:
Miriam Koopman, Felix E de Jongh, Ankie M.T. van der Velden, Bram Dorresteijn, Sophie A Kurk, Pim A. de Jong, Geert-Jan Creemers, Petra H.M. Peeters, Frans L. G. Erdkamp, Marion Jourdan, Anne M May, Peter A M Kint, Boelo J Poppema, Lieke H.J. Simkens, Manuel L. R. Tjin-A-Ton, B.C. Tanis, Cornelis J. A. Punt, Sandra A Radema
Publikováno v:
Cancer Medicine, 9(3), 1033. John Wiley and Sons Ltd
Cancer Medicine
Cancer Medicine, Vol 9, Iss 3, Pp 1033-1043 (2020)
Cancer medicine, 9(3), 1033-1043. John Wiley and Sons Ltd
Cancer Medicine, 9, 1033-1043
Cancer Medicine, 9, 3, pp. 1033-1043
Cancer Medicine
Cancer Medicine, Vol 9, Iss 3, Pp 1033-1043 (2020)
Cancer medicine, 9(3), 1033-1043. John Wiley and Sons Ltd
Cancer Medicine, 9, 1033-1043
Cancer Medicine, 9, 3, pp. 1033-1043
Background Low skeletal muscle index (SMI) in metastatic colorectal cancer (mCRC) patients is associated with poor outcomes. The prognostic impact of SMI changes during consecutive palliative systemic treatments is unknown. Methods This is a retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9423fcb999920710eadfa5693d7cdcb6
https://dspace.library.uu.nl/handle/1874/395432
https://dspace.library.uu.nl/handle/1874/395432
Autor:
Wouter E.M. Kok, Lieke H.J. Simkens, Linda Mol, Johannes J.M. Kwakman, Cornelis J. A. Punt, Miriam Koopman
Publikováno v:
European journal of cancer (Oxford, England, 76, 93-99. Elsevier Limited
European Journal of Cancer, 76, 93. Elsevier Limited
European Journal of Cancer, 76, 93. Elsevier Limited
Background The frequency of capecitabine-related cardiotoxicity has been reported to be low but includes serious adverse events. We conducted a retrospective analysis of the incidence and severity of capecitabine-related cardiotoxicity in different r
Autor:
Cornelis J. A. Punt, Manuel L. R. Tjin-A-Ton, Petra H.M. Peeters, B.C. Tanis, Ankie M.T. van der Velden, Felix E de Jongh, Bram Dorresteijn, Peter A M Kint, Pim de Jong, Geert-Jan Creemers, Sophie A Kurk, Rebecca K. Stellato, Miriam Koopman, A. M. May, Lieke H.J. Simkens, Marion Jourdan, Frans L. G. Erdkamp
Publikováno v:
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 10(4), 803-813. Wiley-Blackwell
Journal of Cachexia, Sarcopenia and Muscle, Vol 10, Iss 4, Pp 803-813 (2019)
Journal of Cachexia, Sarcopenia and Muscle, 10(4), 803. Wiley-Blackwell
Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, Vol 10, Iss 4, Pp 803-813 (2019)
Journal of Cachexia, Sarcopenia and Muscle, 10(4), 803. Wiley-Blackwell
Journal of Cachexia, Sarcopenia and Muscle
Background Increasing evidence suggests that severe skeletal muscle index (SMI) loss (sarcopenia) is associated with poor overall survival in metastatic colorectal cancer patients, but its mechanisms are unknown. We recently found, using data of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bd37faf96655e2b511007c5e1839fd2
https://pure.amc.nl/en/publications/skeletal-muscle-mass-loss-and-doselimiting-toxicities-in-metastatic-colorectal-cancer-patients(2887e29c-c41f-4f79-8562-1e59ae142ea7).html
https://pure.amc.nl/en/publications/skeletal-muscle-mass-loss-and-doselimiting-toxicities-in-metastatic-colorectal-cancer-patients(2887e29c-c41f-4f79-8562-1e59ae142ea7).html
Autor:
Lieke H.J. Simkens, A.M.T. van der Velden, C.J.A. Punt, A.J. van de Wouw, Mathijs P. Hendriks, G.J.M. Creemers, T. Van Voorthuizen, A.J. ten Tije, R.J. van Alphen, M. Los, Linda Mol, Johannes J.M. Kwakman, M. Koopman, Erik W. Muller, E. van Werkhoven, Marco B. Polee, J. M. van Rooijen
Publikováno v:
Annals of Oncology. 30:v233-v234
Background SALTO is a multi-center, open-label phase III trial in which 161 Western patients with metastatic colorectal cancer (mCRC) were randomized between capecitabine and S-1. The primary endpoint, a lower incidence of hand-foot syndrome (HFS) fo
Autor:
Erik W. Muller, Cornelis J. A. Punt, Ankie M.T. van der Velden, Robbert J. van Alphen, Theo van Voorthuizen, Linda Mol, Johannes J.M. Kwakman, Johan M van Rooijen, Yes A J van de Wouw, Albert J. ten Tije, Mathijs P. Hendriks, Miriam Koopman, Marco B. Polee, Geert-Jan Creemers, Erik van Werkhoven, Maartje Los, Lieke H.J. Simkens
Publikováno v:
Clinical colorectal cancer, 18(2), e229-e230. Elsevier
Autor:
C.J.A. Punt, Sophie A Kurk, Bram Dorresteijn, Marion Jourdan, P. H. M. Peeters, B.C. Tanis, Miriam Koopman, Peter A M Kint, Manuel L. R. Tjin-A-Ton, Geert Jan Creemers, A. M. May, A.M.T. van der Velden, Lieke H.J. Simkens, Frans L. G. Erdkamp, Felix E de Jongh, Boelo Jan Poppema, Rebecca K. Stellato, Sandra A Radema
Publikováno v:
Annals of Oncology. 28(suppl_5)
Background: Evidence is increasing that severe skeletal muscle (SM) loss (sarcopenia) is associated with reduced overall survival (OS) in mCRC pts. We recently found, using data of the randomized phase 3 CAIRO3 study (Lancet, 2015), that SM loss was
Publikováno v:
Current opinion in oncology. 26(4):448-453
Het onderzoek zoals beschreven in dit proefschrift richt zich op de optimalisatie van palliatieve systemische behandeling van patienten met een gemetastaseerd colorectaalcarcinoom. Wij vonden dat onderhoudsbehandeling met capecitabine en bevacizumab